High-performance liquid chromatographic assay of metabolites of thioguanine and mercaptopurine in capillary blood

被引:29
作者
Erb, N [1 ]
Haverland, U [1 ]
Harms, MO [1 ]
Escherich, G [1 ]
Janka-Schaub, G [1 ]
机构
[1] Childrens Univ Hosp, Dept Pediat Hematol & Oncol, D-20251 Hamburg, Germany
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2003年 / 796卷 / 01期
关键词
thioguanine; mercaptopurine;
D O I
10.1016/j.jchromb.2003.08.006
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The main metabolites of the cytotoxic drugs thioguanine (6TG) and mercaptopurine (6MP) can be measured conveniently in red blood cells (RBC). Isolation of RBC, however, is laborious and requires some milliliters of blood. This HPLC assay allows measurements of thiopurine metabolites in very small blood samples obtained from the finger-tip. The metabolites, derivatives of 6TG and methylmercaptopurine (6MeMP), were extracted and hydrolized with perchloric acid to liberate the corresponding base. 6MeMP is completely transformed under these conditions to 4-amino-5-(methylthio)carbonyl imidazole. The chromatographic separation of 6TG and this imidazole was performed in a single run under isocratic conditions within 10 min using a 70 mm column. The quantification limit was 0.5 nmol/ml for 6TG and 3 nmol/ml blood for 6MeMP. The accuracy was 83% for 6TG (CV = 3%) over the concentration range of 0.5-20 nmol/ml blood and 102% (CV = 4%) for 6MeMP over the range of 3-150 nmol/ml blood. The intra-assay CV ranged from 5.4 to 7.4% for 6TG and from 6.2 to 10.6% for 6MeMP. The inter-assay CV was 7.5 and 9.5% in a pooled blood sample. The levels in RBC in whole blood were nearly coincident with those obtained in separated RBC, isolation of RBC therefore is not necessary for these measurements, if the drugs are given per os in the day before blood sampling. The concentration of 6MeMP nucleotides is more dependent on the given 6MP dose than the concentration of 6TG nucleotides. Intraindividual variations were small at unchanged drug doses, interindividual metabolite concentrations were highly variable. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:87 / 94
页数:8
相关论文
共 41 条
[1]
Thiopurine biology and pharmacology [J].
Aarbakke, J ;
JankaSchaub, G ;
Elion, GB .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1997, 18 (01) :3-7
[2]
KINETICS OF MERCAPTOPURINE AND THIOGUANINE NUCLEOTIDES IN RENAL-TRANSPLANT RECIPIENTS DURING AZATHIOPRINE TREATMENT [J].
BERGAN, S ;
RUGSTAD, HE ;
BENTDAL, O ;
ENDRESEN, L ;
STOKKE, O .
THERAPEUTIC DRUG MONITORING, 1994, 16 (01) :13-20
[3]
6-MERCAPTOPURINE - CYTOTOXICITY AND BIOCHEMICAL PHARMACOLOGY IN HUMAN-MALIGNANT T-LYMPHOBLASTS [J].
BOKKERINK, JPM ;
STET, EH ;
DEABREU, RA ;
DAMEN, FJM ;
HULSCHER, TW ;
BAKKER, MAH ;
VANBAAL, JA .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (07) :1455-1463
[4]
BOSTROM B, 1993, AM J PEDIAT HEMATOL, V15, P80
[5]
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF THIOPURINE METABOLITES OF AZATHIOPRINE IN BIOLOGICAL-FLUIDS [J].
BOULIEU, R ;
LENOIR, A ;
BORY, C .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1993, 615 (02) :352-356
[6]
BROX LW, 1981, CANCER CHEMOTH PHARM, V6, P35
[7]
ANALYSIS OF 6-MERCAPTOPURINE, 6-THIOGUANINE NUCLEOTIDES, AND 6-THIOURIC ACID IN BIOLOGICAL-FLUIDS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
BRUUNSHUUS, I ;
SCHMIEGELOW, K .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1989, 49 (08) :779-784
[8]
AZATHIOPRINE METABOLISM - PHARMACOKINETICS OF 6-MERCAPTOPURINE, 6-THIOURIC ACID AND 6-THIOGUANINE NUCLEOTIDES IN RENAL-TRANSPLANT PATIENTS [J].
CHAN, GLC ;
ERDMANN, GR ;
GRUBER, SA ;
MATAS, AJ ;
CANAFAX, DM .
JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (04) :358-363
[9]
DITHIOTHREITOL NEW PROTECTIVE REAGENT FOR SH GROUPS [J].
CLELAND, WW .
BIOCHEMISTRY, 1964, 3 (04) :480-&
[10]
Dervieux T, 2002, CLIN CHEM, V48, P61